Keiko Nakahashi

No ORCID on file · 1 paper in corpus · active 2003

Study types

  • article 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
article 2003
A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.
Anticancer research

The inhibitory effects of a novel matrix metalloproteinase inhibitor, ONO-4817, on the development of mammary tumors and the progression of uterine adenomyosis were examined in SHN mice. First, multiparous mice which developed mammary tumor…